Peri-Implantitis
1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Heidelberg PharmaGermany - Ladenburg
1 program1
Air abrasion of the implant surface with a low abrasive powderPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Heidelberg PharmaAir abrasion of the implant surface with a low abrasive powder
SigmaGraftInterOss Collagen
BiolaseEr,Cr:YSGG laser
Geistlich PharmaGBO and GBG
Clinical Trials (4)
Total enrollment: 163 patients across 4 trials
Therapy of Peri-implantitis: Scaling Versus Low Abrasive Powder
Start: Jan 2011Est. completion: Jan 201240 patients
Phase 2Unknown
Surgical Treatment of Peri-implantitis Using a Bone Substitute With or Without a Resorbable Collagen Membrane
Start: Jan 2023Est. completion: Dec 202852 patients
N/AEnrolling By Invitation
Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase
Start: Jan 2019Est. completion: Aug 2021
N/ACompleted
Treatment of Peri-implantitis Lesions by Using Biomaterial
Start: Sep 2014Est. completion: Apr 201771 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space